New guidelines regarding anemia drugs are not good for patients, says the American Society of Clinical Oncology - the guidelines indicate the drugs have some potentially deadly adverse effects. According to ASCO, the new Medicare Program guidelines undermine a doctor’s treatment options for patients with anemia.

Read more here…